Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab with Atorvastatin in Primary Hypercholesterolemia
NCT01288469Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2011
- Primary completion
- Sep 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alirocumab in hypercholesterolemia, sponsored by Sanofi. Started Jan 2011; status: completed.
02
Drugs
alirocumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01288469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288469.